Wednesday, October 14, 2026
Researchers figure out how to keep clocks on the Earth, Moon in sync
Latest Posts Technology News

Researchers figure out how to keep clocks on the Earth, Moon in sync

Enlarge / Without adjustments for relativity, clocks here and on the Moon would rapidly diverge. (credit: NASA) Timing is everything these days. Our communications and GPS networks all depend on keeping careful track of the precise timing of signals—including accounting for the effects of relativity. The deeper into a gravitational well you go, the slower…

Kioxia Demonstrates Optical Interface SSDs for Data Centers
Latest Posts Technology News

Kioxia Demonstrates Optical Interface SSDs for Data Centers

A few years back, the Japanese government's New Energy and Industrial Technology Development Organization (NEDO ) allocated funding for the development of green datacenter technologies. With the aim to obtain up to 40% savings in overall power consumption, several Japanese companies have been developing an optical interface for their enterprise SSDs. And at this year's…

Silicon Motion Demonstrates Flexible Data Placement on MonTitan Gen 5 Enterprise SSD Platform
Latest Posts Technology News

Silicon Motion Demonstrates Flexible Data Placement on MonTitan Gen 5 Enterprise SSD Platform

At FMS 2024, the technological requirements from the storage and memory subsystem took center stage. Both SSD and controller vendors had various demonstrations touting their suitability for different stages of the AI data pipeline - ingestion, preparation, training, checkpointing, and inference. Vendors like Solidigm have different types of SSDs optimized for different stages of the…

MDMA for PTSD: Three studies retracted on heels of FDA rejection
Latest Posts Technology News

MDMA for PTSD: Three studies retracted on heels of FDA rejection

Enlarge / MDMA (credit: Getty | PYMCA/Avalon) A scientific journal has retracted three studies underpinning the clinical development of MDMA—aka ecstasy—as a psychedelic treatment for post-traumatic stress disorder. The move came just a day after news broke that the Food and Drug Administration rejected the treatment, despite positive results reported from two Phase III clinical…